Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Tenaya Therapeutics, Inc. (TNYA) had Non-Operating Income/Expense of $2.73M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-90.60M |
|
-- |
|
-- |
|
$93.33M |
|
$-93.33M |
|
|
Non-Operating Income/Expense |
$2.73M |
$-90.60M |
|
$-90.60M |
|
$-90.60M |
|
$-90.60M |
|
$-90.60M |
|
$-90.60M |
|
$-93.33M |
|
$-84.48M |
|
152.97M |
|
152.97M |
|
$-0.59 |
|
$-0.59 |
|
| Balance Sheet Financials | |
$105.59M |
|
$27.67M |
|
$41.34M |
|
$146.92M |
|
$15.44M |
|
-- |
|
$8.22M |
|
$23.66M |
|
$123.27M |
|
$123.27M |
|
$123.27M |
|
216.76M |
|
| Cash Flow Statement Financials | |
$-68.26M |
|
$56.08M |
|
$108.41M |
|
$4.74M |
|
$100.97M |
|
$96.22M |
|
$13.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-68.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-73.50% |
|
-73.50% |
|
-61.66% |
|
-73.50% |
|
$0.57 |
|
$-0.45 |
|
$-0.45 |
|